Development and application of culturally appropriate decision aids for smoking cessation in Korea: A pragmatic clustered randomization crossover trial

Patient Preference and Adherence

Volumn 10, Issue , 2016, Pages 1929-1936

  Lee, Ji Eun ^a   Shin, Dong Wook ^a,c   Suh, Beomseok ^a   Chun, Sohyun ^d   Nam, You Seon ^c   Cho, Belong ^a,b  

^a Health Promotion Center   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Clustered randomized trial; Decision aids; Korea; Smoking

Indexed keywords

ADULT; CONSULTATION; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; KOREA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MIDDLE AGED; ODDS RATIO; PHYSICIAN; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; VIDEORECORDING;

EID: 85016102029     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S114387     Document Type: Article

References (41)

1. West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Thorax. 2000;55(12):987–999.
2. Hung WT, Dunlop SM, Perez D, Cotter T. Use and perceived helpfulness of smoking cessation methods: results from a population survey of recent quitters. BMC Public Health. 2011;11(1):592.
3. Shin DW, Suh B, Chun S, et al. The prevalence of and factors associated with the use of smoking cessation medication in Korea: trend between 2005–2011. PLoS One. 2013;8(10):e74904.
4. Fagerström K, Nakamura M, Cho HJ, et al. Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebocontrolled trials conducted in six Asian countries. Curr Med Res Opin. 2010;26(9):2165–2173.
5. Shiffman S, Brockwell SE, Pillitteri JL, Gitchell JG. Use of smokingcessation treatments in the United States. Am J Prev Med. 2008;34(2): 102–111.
6. Kotz D, Fidler J, West R. Factors associated with the use of aids to cessation in English smokers. Addiction. 2009;104(8):1403–1410.
7. Etter JF, Perneger TV. Attitudes toward nicotine replacement therapy in smokers and ex-smokers in the general public. Clin Pharmacol Ther. 2001;69(3):175–183.
8. Lee HH. Present status and prospect of national policies on smoking cessation and prevention. Health and Welfare Policy Forum; 2007.
9. Ministry of Health and Welfare. Korea Health Statistics 2013: Korea National Health and Nutrition Examination Survey (KNHANES VI-1). Cheongju: Korea Centers for Disease Control and Prevention; 2014.
10. Kim CH, Song HR, Lee WS, Kim JY. Attitudes toward smoking cessation intervention and services among Korean physicians: a questionnaire survey. Korean J Fam Med. 2009;30(11):857–863.
11. Fong TW, Tsuang J. Asian-Americans, addictions, and barriers to treatment. Psychiatry (Edgmont). 2007;4(11):51–59.
12. Lin KM, Shen WW. Pharmacotherapy for Southeast Asian psychiatric patients. J Nerv Ment Dis. 1991;179(6):346–350.
13. Kim SS, Son H, Nam KA. Personal factors influencing Korean American men’s smoking behavior: addiction, health, and age. Arch Psychiatr Nurs. 2005;19(1):35–41.
14. Ishisaka HA, Nguyen QT, Okimoto JT. The role of culture in the mental health treatment of Indochinese refugees. In: Owan TC, editor. Southeast Asian Mental Health: Treatment, Prevention, Services, Training and Research. Vol. 85. Washington, DC: US DHHS; 1985:54. DOCUMENT RESUME ED 266 199 UD 024 683.
15. Uba L. Cultural barriers to health care for Southeast Asian refugees. Public Health Rep. 1992;107(5):544.
16. Willemsen MC, Wiebing M, Van Emst A, Zeeman G. Helping smokers to decide on the use of efficacious smoking cessation methods: a randomized controlled trial of a decision aid. Addiction. 2006;101(3): 441–449.
17. Pang KYC. Symptoms of depression in elderly Korean immigrants: narration and the healing process. Cult Med Psychiatry. 1998;22(1): 93–122.
18. Hull SA, Cornwell J, Harvey C, Eldridge S, Bare PO. Prescribing rates for psychotropic medication amongst east London general practices: low rates where Asian populations are greatest. Fam Pract. 2001; 18(2):167–173.
19. Shin JK. Help-seeking behaviors by Korean immigrants for depression. Issues Ment Health Nurs. 2002;23(5):461–476.
20. Hussain FA, Cochrane R. Depression in South Asian women: Asian women’s beliefs on causes and cures. Ment Health Relig Cult. 2002; 5(3):285–311.
21. Yeung A. How culture impacts on the treatment of mental illnesses among Asian-Americans. Psychiatric Times. 2004;21(1):34.
22. Donnelly PL. Mental health beliefs and help seeking behaviors of Korean American parents of adult children with schizophrenia. J Multicult Nurs Health. 2005;11(2):23.
23. Jones RS, Chow TW, Gatz M. Asian Americans and Alzheimer’s disease: assimilation, culture, and beliefs. J Aging Stud. 2006;20(1):11–25.
24. Heatherton TF, Kozlowski LT, Frecker RC. The Fagerström test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119–1127.
25. DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS. The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol. 1991;59(2):295–304.
26. Ahn HK, Lee HJ, Jeong DS, Lee SY, Kim SW, Kang JH. Reliability and validity of Korean version of Fagerstrom Tolerance Questionnaire and Fagerstrom Test for Nicotine Dependence. J Korean Acad Fam Med. 2002;23(8):999–1008.
27. DiClemente CC, Nidecker M, Bellack AS. Motivation and the stages of change among individuals with severe mental illness and substance abuse disorders. J Subst Abuse Treat. 2008;34(1):25–35.
28. Hodgins D, Peden N, Makarchuk K. Self-efficacy in pathological gambling treatment outcome: development of a gambling abstinence self-efficacy scale (GASS). Int Gambl Stud. 2004;4(2):99–108.
29. Han M, Kim K, Park J, Kang M, Ryu S. Association between levels of physical activity and poor self-rated health in Korean adults: the Third Korea National Health and Nutrition Examination Survey (KNHANES), 2005. Public Health. 2009;123(10):665–669.
30. Kim M, Chung W, Lim S, et al. Socioeconomic inequity in self-rated health status and contribution of health behavioral factors in Korea. J Prev Med Public Health. 2010;43(1):50–61.
31. Puffer S, Torgerson D, Watson J. Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals. BMJ. 2003;327(7418):785–789.
32. Eldridge SM, Ashby D, Feder GS. Informed patient consent to participation in cluster randomized trials: an empirical exploration of trials in primary care. Clin Trials. 2005;2(2):91–98.
33. Moore L, Campbell R, Whelan A, et al. Self help smoking cessation in pregnancy: cluster randomised controlled trial. BMJ. 2002; 325(7377):1383.
34. Lawrence T, Aveyard P, Cheng K, Griffin C, Johnson C, Croghan E. Does stage-based smoking cessation advice in pregnancy result in long-term quitters? 18-month postpartum follow-up of a randomized controlled trial. Addiction. 2005;100(1):107–116.
35. Aveyard P, Cheng K, Almond J, et al. Cluster randomised controlled trial of expert system based on the transtheoretical (“stages of change”) model for smoking prevention and cessation in schools. BMJ. 1999;319(7215):948–953.
36. Campbell MK, Mollison J, Steen N, Grimshaw JM, Eccles M. Analysis of cluster randomized trials in primary care: a practical approach. Fam Pract. 2000;17(2):192–196.
37. Sandra Eldridge [webpage on the Internet]. Sample Size in Cluster Randomised Trials. Available from: https://www.newton.ac.uk/files/seminar/20110815152516051-152821.pdf. Accessed January 8, 2013.
38. Rollnick S, Miller WR. What is motivational interviewing? Behav Cogn Psychother. 1995;23(04):325–334.
39. Shiffman S, Ferguson SG, Rohay J, Gitchell JG. Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance. Addiction. 2008; 103(8):1371–1378.
40. Kasza KA, Cummings KM, Carpenter MJ, Cornelius ME, Hyland AJ, Fong GT. Use of stop-smoking medications in the United States before and after the introduction of varenicline. Addiction. 2015;110(2): 346–355.
41. Ziegler DK, Mosier MC, Buenaver M, Okuyemi K. How much information about adverse effects of medication do patients want from physicians? Arch Intern Med. 2001;161(5):706–713.